Evidence map›Paper›PMID 24167196›Full record

ArticleBlood2014

Pharmacologic increase in HIF1α enhances hematopoietic stem and progenitor homing and engraftment.

Jennifer M Speth, Jonathan Hoggatt, Pratibha Singh, Louis M Pelus

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Ex Vivo Expansion and Homing of Human Cord Blood Hematopoietic Stem Cells.Advances in experimental medicine and biology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Prostaglandin EStem cell reviews and reports · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Hypoxia-inducible factor 1α (HIF-1α) is a major determinant in the enhanced function of muscle-derived progenitors from MRL/MpJ mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jennifer M SpethDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN; and.
Jonathan Hoggatt
Pratibha Singh
Louis M Pelus
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Jun Wan · 1999 to 2026
$59.3M
BASIC SCIENCE STUDIES ON GENE THERAPY OF BLOOD DISEASEST32HL007910 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Roland W. Herzog, Reuben Kapur · 1999 to 2026
$7.6M
REGULATION OF HEMATOPOIETIC CELL PRODUCTIONT32DK007519 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI KAPLAN, MARK H · 1986 to 2020
$7.1M
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacyP30DK090948 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI BROXMEYER, HAL E., SROUR, EDWARD F · 2010 to 2014
$3.7M
Role of PGE2 and other eicosanoids in hematopoietic stem cell functionR01HL096305 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI PELUS, LOUIS M · 2010 to 2018
$3.5M
Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral FellowsT32HL087735 · NHLBI · HARVARD UNIVERSITY · PI SCADDEN, DAVID T · 2008 to 2012
$1.7M
NCI NIH HHS P30 CA082709NHLBI NIH HHS HL07910NHLBI NIH HHS HL087735NHLBI NIH HHS HL096305NHLBI NIH HHS R01 HL096305NHLBI NIH HHS T32 HL007910NHLBI NIH HHS T32 HL087735NIDDK NIH HHS DK07519NIDDK NIH HHS P01 DK090948NIDDK NIH HHS P30 DK090948NIDDK NIH HHS T32 DK007519
6 · The paper itself

Abstract

Hematopoietic stem cell (HSC) transplantation is a lifesaving therapy for a number of immunologic disorders. For effective transplant, HSCs must traffic from the peripheral blood to supportive bone marrow niches. We previously showed that HSC trafficking can be enhanced by ex vivo treatment of hematopoietic grafts with 16-16 dimethyl prostaglandin E2 (dmPGE2). While exploring regulatory molecules involved in dmPGE2 enhancement, we found that transiently increasing the transcription factor hypoxia-inducible factor 1-α (HIF1α) is required for dmPGE2-enhanced CXCR4 upregulation and enhanced migration and homing of stem and progenitor cells and that pharmacologic manipulation of HIF1α is also capable of enhancing homing and engraftment. We also now identify the specific hypoxia response element required for CXCR4 upregulation. These data define a precise mechanism through which ex vivo pulse treatment with dmPGE2 enhances the function of hematopoietic stem and progenitor cells; these data also define a role for hypoxia and HIF1α in enhancement of hematopoietic transplantation.

Indexed as

Hematopoietic Stem Cell MobilizationHematopoietic Stem Cell TransplantationAnimalsDinoprostoneGene Expression RegulationGraft SurvivalHematopoietic Stem CellsHypoxia-Inducible Factor 1, alpha SubunitMiceReceptors, CXCR4Transcription, GeneticDinoprostoneHypoxia-Inducible Factor 1, alpha SubunitReceptors, CXCR4

Identifiers

PMID24167196
PMCPMC3888286
OpenAlexW1985050935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.